SATO has released a white paper, suggesting ways that pharmaceutical companies can prevent counterfeit drugs from entering the supply chain.
The whitepaper, Track/Trace Solutions for the Healthcare and Pharmaceutical Industries, advises pharmaceutical companies that track and trace solutions, including barcoding and RFID technologies, must be implemented as soon as possible.
“SATO’s barcode and RFID track and trace solutions can help those in the pharmaceutical industry to save time, reduce costs, increase efficiency and improve productivity,” said Brian Lang, SATO International Europe’s Managing Director.
“It can also help to increase consumer safety by eliminating the opportunities for counterfeit drugs to enter the supply chain.
“This white paper will be useful for anyone looking to find out more on how SATO can provide its innovative range of products and wealth of expertise to ensure best practice in their organisation”.